横田 めぐみ

Medicine & Life Sciences

1. Endometrial Neoplasms 100%
2. Hypertriglyceridemia 74%
3. Cancer Survivors 71%
4. Ovarian Neoplasms 67%
5. Salpingo-oophorectomy 59%
6. Osteoporosis 57%
7. ERRalpha estrogen-related receptor 53%
8. Coronavirus 40%
9. Tokyo 38%
10. Middle Aged 32%
11. Uterine Cervical Neoplasms 32%
12. Dyslipidemias 32%
13. Epidemics 27%
14. Cross-Sectional Studies 27%
15. Japan 26%
16. Estrogens 26%
17. Body Mass Index 23%
18. Neoplasms 21%
19. Thinness 21%
20. Menopause 17%
21. Premenopause 16%
22. Time-to-Treatment 16%
23. Postmenopause 14%
24. Estrogen Receptor alpha 14%
25. Arthralgia 13%
26. Genes 13%
27. Reverse Transcriptase Polymerase Chain Reaction 11%
28. Overweight 11%
29. Bone Density 10%
30. Quality of Life 10%
31. Anxiety 9%
32. Hereditary Breast and Ovarian Cancer Syndrome 9%
33. Mutation 9%
34. Hysterectomy 8%
35. Genetic Polymorphisms 8%
36. LDL Cholesterol 8%
37. HDL Cholesterol 8%
38. Weights and Measures 8%
39. Emerging Communicable Diseases 8%
40. Constitution and Bylaws 7%
41. Sweat 7%
42. Laser Capture Microdissection 7%
43. Hypesthesia 7%
44. Follicle Stimulating Hormone 7%
45. Hereditary Nonpolyposis Colorectal Neoplasms 7%
46. Veins 6%
47. Ovarian Epithelial Carcinoma 6%
48. Tomography 6%